Key result
Vi-ΔVP8 conjugate vaccine induces higher Salmonella Typhi and Rotavirus antibodies vs single antigens in mice.
Why the study?
Carrier proteins in conjugate vaccines can act as immunogens, but this is generally not considered as a measured outcome in the real world.
Answers are grounded in this paper and cite their sources.
Supports bivalent vaccine development; leaves open human immunogenicity and efficacy trials.
Conjugate vaccine platform is a promising strategy to overcome the poor immunogenicity of bacterial polysaccharide antigens in infants and children. A carrier protein in conjugate vaccines works not only as an immune stimulator to polysaccharide, but also as an immunogen; with the latter generally not considered as a measured outcome in real world. Here, we probed the potential of a conjugate vaccine platform to induce enhanced immunogenicity of a truncated rotavirus spike protein ΔVP8*. ΔVP8* was covalently conjugated to Vi capsular polysaccharide (Vi) of Salmonella Typhi to develop a bivalent vaccine, termed Vi-ΔVP8*. Our results demonstrated that the Vi-ΔVP8* vaccine can induce specific immune responses against both antigens in immunized mice. The conjugate vaccine elicits high antibody titers and functional antibodies against S. Typhi and Rotavirus (RV) when compared to immunization with a single antigen. Together, these results indicate that Vi-ΔVP8* is a potent and immunogenic vaccine candidate, thus strengthening the potential of conjugate vaccine platform with enhanced immune responses to carrier protein, including ΔVP8*.
No takes yet. Share an insight, caveat, or question.
Park et al. (2021) studied Rotavirus and Salmonella Typhi infection (vaccine development) (n=90). Vi-ΔVP8 conjugate vaccine vs. Vi polysaccharide alone, ΔVP8 alone, or PBS was evaluated on Anti-Vi and anti-ΔVP8 IgG antibody titers and functional antibodies (SBA and PRNT). The Vi-ΔVP8 conjugate vaccine induced high specific IgG and functional antibodies against both Salmonella Typhi and Rotavirus in immunized mice compared to immunization with a single antigen.
Synapse has enriched 10 related papers. Consider them for comparative context: